Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00822185
What this trial is testing

Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers

Who this might be right for
Congenital Bleeding DisorderHealthy
Novo Nordisk A/S 32
Early research (Phase 1)Study completedNCT04542252
What this trial is testing

Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects

Who this might be right for
Drug Drug Interaction
SymBio Pharmaceuticals 13
Early research (Phase 1)Study completedNCT02207790
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects

Who this might be right for
Healthy Subjects
Eisai Inc. 32
Early research (Phase 1)Study completedNCT01835197
What this trial is testing

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Who this might be right for
Healthy
Pfizer 79
Early research (Phase 1)Study completedNCT01424163
What this trial is testing

Dexpramipexole Japanese PK Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 57
Early research (Phase 1)WithdrawnNCT01691872
What this trial is testing

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline
Early research (Phase 1)Study completedNCT00543946
What this trial is testing

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Who this might be right for
Arrhythmia
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT01565018
What this trial is testing

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteers
UCB Pharma 55
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Early research (Phase 1)Study completedNCT05288816
What this trial is testing

Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 16
Post-approval studies (Phase 4)Study completedNCT03123848
What this trial is testing

Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT01868555
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Early research (Phase 1)Study completedNCT01595425
What this trial is testing

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

Who this might be right for
Bioequivalence Study
AstraZeneca 71
Early research (Phase 1)Study completedNCT00415883
What this trial is testing

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Who this might be right for
Healthy
Novartis 40
Early research (Phase 1)Study completedNCT01167868
What this trial is testing

Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects

Who this might be right for
Healthy
AstraZeneca 56
Early research (Phase 1)Study completedNCT00930215
What this trial is testing

Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males

Who this might be right for
Healthy
AstraZeneca 48
Early research (Phase 1)Study completedNCT01268124
What this trial is testing

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT01100047
What this trial is testing

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069

Who this might be right for
Healthy
AstraZeneca 63
Early research (Phase 1)Study completedNCT04497883
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Who this might be right for
Healthy Volunteers
Shire 24
Early research (Phase 1)Study completedNCT03586570
What this trial is testing

Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation